| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
| | FI | | | Methotrexat Teva Onco 50 mg/2 ml | | 8.06 | 25.20 | 10% | | Infusionslösung: Methotrexatum 50mg / 2ml | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Methotrexat Teva Onco 500 mg/20 ml | | 52.47 | 73.50 | 10% | | Infusionslösung: Methotrexatum 500mg / 20ml | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Methotrexat Teva Onco 5000 mg/50 ml | | 314.54 | 358.50 | 10% | | Infusionslösung: Methotrexatum 5000mg / 50ml | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Methotrexat Sandoz 5 mg | 20 | 8.25 | 25.40 | 10% | | Tabletten: Methotrexatum 5 mg | Sandoz Pharmaceuticals AG | ● A / SL / SG | FB | | G |  |
| | FI | PI | | Methotrexat Sandoz 10 mg | 10 | 6.47 | 16.25 | 10% | | Tabletten: Methotrexatum 10 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Methotrexat Sandoz 5000 mg | 50 ml | 314.54 | 358.50 | 10% | | Konzentrat zur Herstellung einer Injektions-/Infusionslösung: Methotrexatum | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Methotrexat Teva Onco 5 mg/2 ml | | 2.99 | 7.55 | k.A. | | Infusionslösung: Methotrexatum 5mg / 2ml | Teva Pharma AG | A | FB | | G |  |
| | FI | | | Methotrexat Teva Onco 1000 mg/10 ml | | 90.25 | 120.00 | k.A. | | Infusionslösung: Methotrexatum 1000mg / 10ml | Teva Pharma AG | A | FB | | G |  |
| | FI | | | Methotrexat Sandoz 1000 mg | 10 ml | 81.00 | 109.40 | k.A. | | Konzentrat zur Herstellung einer Injektions-/Infusionslösung: Methotrexatum | Sandoz Pharmaceuticals AG | A | FB | | G |  |
|
| | FI | PI | | Puri-Nethol | 25 Tablette(n) | 61.10 | 82.85 | 10% | | Tabletten: Mercaptopurinum Monohydricum 50 mg | Ipsen Pharma Schweiz GmbH | A / SL | FB | | G |  |
| | FI | PI | | Xaluprine 20 mg/ml | 100 ml | PA | PA | k.A. | | Suspension (oral): Mercaptopurinum Monohydricum 20 mg/ml | Lipomed AG | A | FB | | G |  |
|
L | | FI | | | Litak 10 | Durchstechflasche(n) | 318.12 | 362.40 | 10% | | Injektions- / Infusionslösung: Cladribinum 10mg / 5ml | Lipomed AG | A / SL | FB | | G |  |
L | | FI | | | Litak 10 | 5 Durchstechflasche(n) | 1503.82 | 1651.90 | 10% | | Injektions- / Infusionslösung: Cladribinum 10mg / 5ml | Lipomed AG | A / SL | FB | | G |  |
|
L | | FI | | | Fludarabin Accord 25 mg/ml | | 135.43 | 163.70 | 10% | | Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Fludarabini Phosphas 50mg / 2ml | Accord Healthcare AG | ● A / SL / SG | FB | | G |  |
L | | FI | | | Fludarabin-Teva | Durchstechflasche(n) à 50 mg | 135.43 | 163.70 | 10% | | Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Fludarabini Phosphas 50mg / 2ml | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
|
| | FI | | | Cytosar Solution 100 mg/5 ml | Durchstechflasche(n) | 3.57 | 13.10 | 10% | | Injektionslöung: Cytarabinum 100 mg | Pfizer AG | A / SL / SO | FB | | G |  |
| | FI | | | Cytosar Solution 2 g/20 ml | Durchstechflasche(n) | 54.19 | 75.35 | 10% | | Injektionslöung: Cytarabinum 2000 mg | Pfizer AG | A / SL / SO | FB | | G |  |
| | | | | Cytarabine Pharmintraco 500 mg | Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 500mg / 5ml | Pharmintraco Sagl | A | FB | | G |  |
| | | | | Cytarabine Pharmintraco 1000 mg | Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 1000mg / 10ml | Pharmintraco Sagl | A | FB | | G |  |
| | | | | Cytarabine Pharmintraco 2000 mg | Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 2000mg / 20ml | Pharmintraco Sagl | A | FB | | G |  |
| | | | | Cytarabine Pharmintraco 500 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 500mg / 5ml | Pharmintraco Sagl | A | FB | | G |  |
| | | | | Cytarabine Pharmintraco 1000 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 1000mg / 10ml | Pharmintraco Sagl | A | FB | | G |  |
| | | | | Cytarabine Pharmintraco 2000 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | soluzione iniettabile / per infusione: Cytarabinum 2000mg / 20ml | Pharmintraco Sagl | A | FB | | G |  |
|
| | FI | | | Fluorouracil Accord 250 mg/5 ml | | 2.90 | 12.40 | 10% | | Infusionslösung: Fluorouracilum 250mg / 5ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Accord 500 mg/10 ml | | 4.25 | 13.85 | 10% | | Infusionslösung: Fluorouracilum 500mg / 10ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Accord 1000 mg/20 ml | | 6.65 | 16.45 | 10% | | Infusionslösung: Fluorouracilum 1000mg / 20ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Accord 2500 mg/50 ml | | 14.90 | 32.60 | 10% | | Infusionslösung: Fluorouracilum 2500mg / 50ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Accord 5000 mg/100 ml | | 26.60 | 45.35 | 10% | | Infusionslösung: Fluorouracilum 5000mg / 100ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil-Teva | Durchstechflasche(n) à 250 mg | 3.00 | 12.50 | 10% | | Infusionslösung: Fluorouracilum 50 mg/ml | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil-Teva | Durchstechflasche(n) à 500 mg | 4.38 | 14.00 | 10% | | Infusionslösung: Fluorouracilum 50 mg/ml | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil-Teva | Durchstechflasche(n) à 1000 mg | 6.80 | 16.60 | 10% | | Infusionslösung: Fluorouracilum 50 mg/ml | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil-Teva | Durchstechflasche(n) à 5000 mg | 27.18 | 45.95 | 10% | | Infusionslösung: Fluorouracilum 50 mg/ml | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Sandoz 250 mg/5 ml | Durchstechflasche(n) | 2.94 | 12.45 | 10% | | Injektionslösung: Fluorouracilum 250mg / 5ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Sandoz 500 mg/10 ml | Durchstechflasche(n) | 4.29 | 13.90 | 10% | | Injektionslösung: Fluorouracilum 500mg / 10ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Sandoz 1000 mg/20 ml | Durchstechflasche(n) | 6.65 | 16.45 | 10% | | Injektionslösung: Fluorouracilum 1000mg / 20ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Sandoz 5000 mg/100 ml | Durchstechflasche(n) | 26.63 | 45.40 | 10% | | Injektionslösung: Fluorouracilum 5000mg / 100ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Labatec 250 mg/5 ml | | 2.97 | 12.45 | 10% | | Solution injectable/pour perfusion: Fluorouracilum 250mg / 5ml | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Labatec 500 mg/10 ml | | 4.34 | 13.95 | 10% | | Solution injectable/pour perfusion: Fluorouracilum 500mg / 10ml | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Labatec 1000 mg/20 ml | | 6.73 | 16.55 | 10% | | Solution injectable/pour perfusion: Fluorouracilum 1000mg / 20ml | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | | | Fluorouracil Labatec 5000 mg/100 ml | | 26.91 | 45.70 | 10% | | Solution injectable/pour perfusion: Fluorouracilum 5000mg / 100ml | Labatec Pharma SA | A / SL / SG | FB | | G |  |
| | FI | PI | | Efudix | 20 g | 26.78 | 45.55 | 10% | | Crème: Fluorouracilum 50 mg | MEDA Pharmaceuticals Switzerland GmbH | A / SL | FB | | G |  |
| | FI | PI | | Tolak 40 mg/g | 20 g | 26.78 | 45.55 | 10% | | Crème: Fluorouracilum 40 mg | Pierre Fabre Pharma SA | A / SL | FB | | G |  |
| | FI | | | Fluorouracil Sandoz 2500 mg/50 ml | Durchstechflasche(n) | 14.97 | 32.70 | k.A. | | Injektionslösung: Fluorouracilum 2500mg / 50ml | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | PI | | Tolak 40 mg/g | 40 g | PA | PA | k.A. | | Crème: Fluorouracilum 40 mg | Pierre Fabre Pharma SA | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 250 mg/5 ml | Durchstechflasche(n) à 5 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum 250mg / 5ml | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 500 mg/10 ml | Durchstechflasche(n) à 10 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum 500mg / 10ml | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 1000 mg/20 ml | Durchstechflasche(n) à 20 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 250 mg/5 ml | 10 1 Durchstechflasche(n) à 5 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum 250mg / 5ml | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 500 mg/10 ml | 10 1 Durchstechflasche(n) à 10 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum 500mg / 10ml | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 5000 mg/100 ml | Durchstechflasche(n) à 100 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 1000 mg/20 ml | 10 1 Durchstechflasche(n) à 20 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Fluorouracil Pharmintraco 5000 mg/100 ml | 10 1 Durchstechflasche(n) à 100 ml | PA | PA | k.A. | | solution pour injection/perfusion: Fluorouracilum | Pharmintraco Sagl | A | FB | | G |  |
|
| | FI | | | Gemcitabin Sandoz 200 mg/20 ml | Durchstechflasche(n) | 19.52 | 37.60 | 10% | | Infusionslösung: Gemcitabinum 200mg / 20ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 500 mg/50 ml | Durchstechflasche(n) | 65.00 | 87.10 | 10% | | Infusionslösung: Gemcitabinum 500mg / 50ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 1000 mg/100 ml | Durchstechflasche(n) | 90.25 | 114.45 | 10% | | Infusionslösung: Gemcitabinum 1000mg / 100ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Accord 200 mg/2 ml | | 18.80 | 36.85 | 10% | | Infusionskonzentrat: Gemcitabinum 200mg / 2ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Accord 1000 mg/10 ml | | 90.25 | 114.45 | 10% | | Infusionskonzentrat: Gemcitabinum 1000mg / 10ml | Accord Healthcare AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Accord 2000 mg/20 ml | | 172.92 | 204.25 | 10% | | Infusionskonzentrat: Gemcitabinum 2000mg / 20ml | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 200 mg/5 ml | Flasche(n) | 19.52 | 37.60 | 10% | | Infusionskonzentrat: Gemcitabinum 200mg / 5ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 1000 mg/25 ml | Flasche(n) | 90.25 | 114.45 | 10% | | Infusionskonzentrat: Gemcitabinum 1000mg / 25ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Sandoz 2000 mg/50 ml | Flasche(n) | 172.92 | 204.25 | 10% | | Infusionskonzentrat: Gemcitabinum 2000mg / 50ml | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin-Teva liquid 200 mg / 5 ml | | 19.52 | 37.60 | 10% | | Infusionskonzentrat: Gemcitabinum 200mg / 5ml | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin-Teva liquid 1 g / 25 ml | | 90.25 | 114.45 | 10% | | Infusionskonzentrat: Gemcitabinum | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin-Teva liquid 2 g / 50 ml | | 172.92 | 204.25 | 10% | | Infusionskonzentrat: Gemcitabinum | Teva Pharma AG | ● A / SL / SG | FB | | G |  |
| | FI | | | Gemcitabin Accord 1500 mg/15 ml | | PA | PA | k.A. | | Infusionskonzentrat: Gemcitabinum 1500mg / 15ml | Accord Healthcare AG | A | FB | | G |  |
| | FI | | | Gemcitabin-Teva 200 mg | | 19.52 | 37.60 | k.A. | | Lyophilisat: Gemcitabinum 200 mg | Teva Pharma AG | A | FB | | G |  |
| | FI | | | Gemcitabin-Teva 1 g | | 85.00 | 108.85 | k.A. | | Lyophilisat: Gemcitabinum 1000 mg | Teva Pharma AG | A | FB | | G |  |
| | FI | | | Gemcitabin-Teva 2 g | | 160.00 | 200.10 | k.A. | | Lyophilisat: Gemcitabinum 2000 mg | Teva Pharma AG | A | FB | | G |  |
| | FI | | | Gemcitabin DRAC 200mg | Durchstechflasche(n) | PA | PA | k.A. | | | DRAC AG | A | FB | | G |  |
| | FI | | | Gemcitabin DRAC 1g | Durchstechflasche(n) | PA | PA | k.A. | | | DRAC AG | A | FB | | G |  |
| | FI | | | Gemcitabin DRAC 2g | Durchstechflasche(n) | PA | PA | k.A. | | | DRAC AG | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 200 mg | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 200 mg | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 200 mg | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 1 g | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 1 g | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 1000 mg | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 2 g | Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G |  |
| | FI | | | Gemcitabine Pharmintraco 2 g | 10 Durchstechflasche(n) | PA | PA | k.A. | | Concentrato per soluzione per infusione: Gemcitabinum 2000 mg | Pharmintraco Sagl | A | FB | | G |  |
|
| | FI | PI | | Xeloda 150 mg - T | 60 Tablette(n) | 27.35 | 46.00 | 10% | | Filmtabletten: Capecitabinum 150 mg | Cheplapharm Schweiz GmbH | A / SL / SO | FB | | G |  |
| | FI | PI | | Xeloda 500 mg - T | 120 Tablette(n) | 185.34 | 216.95 | 10% | | Filmtabletten: Capecitabinum 500 mg | Cheplapharm Schweiz GmbH | A / SL / SO | FB | | G |  |
| | FI | PI | | Capecitabin Accord 150 mg | 60 | 24.87 | 43.45 | 10% | | Filmtabletten: Capecitabinum 150 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | | | Capecitabin Accord 500 mg | 120 | 168.50 | 199.65 | 10% | | Filmtabletten: Capecitabinum 500 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Capecitabin Zentiva 150 mg | 60 | 24.87 | 43.45 | 10% | | Filmtabletten: Capecitabinum 150 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Capecitabin Zentiva 500 mg | 120 | 168.50 | 199.65 | 10% | | Filmtabletten: Capecitabinum 500 mg | Helvepharm AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Capecitabin-Teva 150 mg | 60 Tablette(n) | 24.87 | 43.45 | 10% | | Filmtabletten: Capecitabinum 150 mg | Teva Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Capecitabin-Teva 500 mg | 120 Tablette(n) | 168.50 | 199.65 | 10% | | Filmtabletten: Capecitabinum 500 mg | Teva Pharma AG | A / SL / SG | FB | | G |  |
|
L | | FI | | | Azacitidin Stada 100 mg | | 218.38 | 253.90 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Stada 150 mg | | 304.64 | 347.75 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 150 mg | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Viatris 100 mg | | 224.25 | 259.95 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Viatris Pharma GmbH | A / SL / SG | FB | | G |  |
L | KFI | FI | | | Vidaza 100 mg | Durchstechflasche(n) | 312.78 | 350.75 | 40% | | Lyophilisat pour suspension injectable: Azacitidinum 100 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
L | | FI | | | Azacitidin Accord 100 mg | | 224.25 | 259.95 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Ideogen 100 mg | | 189.00 | 223.75 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Ideogen AG | A / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Sandoz 100 mg | | 224.25 | 259.95 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | | | Azacitidin Spirig HC 100 mg | | 224.25 | 259.95 | 10% | | Pulver zur Herstellung einer Injektionssuspension: Azacitidinum 100 mg | Spirig HealthCare AG | ● A / SL / SG | FB | | G |  |
| | FI | PI | | Onureg 200 mg | 7 | PA | PA | k.A. | | Filmtabletten: Azacitidinum 200 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | FI | PI | | Onureg 200 mg | 14 | PA | PA | k.A. | | Filmtabletten: Azacitidinum 200 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | FI | | | Onureg 300 mg | 7 | PA | PA | k.A. | | Filmtabletten: Azacitidinum 300 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | FI | | | Onureg 300 mg | 14 | PA | PA | k.A. | | Filmtabletten: Azacitidinum 300 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
|
| | | | | Decitabin Spirig HC 50 mg | | PA | PA | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Spirig HealthCare AG | A | FB | | G |  |
L | | FI | | | Dacogen | Durchstechflasche(n) | 890.92 | 979.75 | 10% | | Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Janssen-Cilag AG | A / SL / SO | FB | | G |  |
L | | FI | | | Decitabin Accord 50 mg | | 799.83 | 886.30 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Accord Healthcare AG | A / SL / SG | FB | | G |  |
L | | FI | | | Decitabin Sandoz 50 mg | | 799.83 | 886.30 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | | | Decitabine Ideogen 50 mg | | 694.22 | 777.90 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Decitabinum 50 mg | Ideogen AG | A / SL / SG | FB | | G |  |
|
| | FI | PI | | Actikerall | 25 ml | 34.81 | 54.25 | 10% | | Lösung: 2 Wirkstoffe | Almirall AG | A / SL | FB | | G |  |
| | FI | PI | | Verrumal | 13 ml | 7.31 | 17.20 | 10% | | Lösung: 2 Wirkstoffe | Almirall AG | A / SL | FB | | G |  |